Stanford Neurosurgery

Caryn Dahm, a patient of Dr. Michael Lim, finds an end from five-years of chronic facial pain and countless doctor visits after receiving cranial nerve surgery at Stanford. Read the full story here: https://lnkd.in/gfwhJzQf . . . . . #surgery #neurosurgery #neurosurgeon #stanford #stanfordneurosurgery #cranialnervesurgery #patientstory #patient

#EpilepsyAwarenessMonth: Deep brain stimulation (DBS) can help reset faulty brain signals that cause symptoms of Parkinson’s disease, essential tremor, and epilepsy. In this procedure, also called neuromodulation, doctors implant a device that produces electrical impulses to disrupt irregular brain signals that cause involuntary movements. Dr. Vivek Buch explains the procedures and how they provide patients with a "new lease on life."

#EpilepsyAwarenessMonth: Corpus callosotomy is an important treatment for atonic seizures (drop attacks) in drug resistant epilepsy. While traditional corpus callosotomy is performed with an open microsurgical approach requiring a craniotomy, Corpus Callosotomy Ablation (CCA) via MR-guided stereotactic laser interstitial thermal therapy (LITT) is an emerging minimally invasive treatment option. This figure demonstrates pre and post op imaging for a patient undergoing open corpus callosotomy (A and B) and corpus callosum ablation (C and D). Learn more: https://lnkd.in/eCNiQaYH

Thank you to the physicians, patients with pituitary disease and their family and friends, who came to the 2024 Pituitary Patient Ed Day on Saturday! We gathered to learn about pituitary disease, the latest medical treatments and surgical innovations, and more. A special thanks to course directors Dr. Juan C. Fernandez-Miranda and Dr. Julia Chang! . . . . #neurosurgery #neurosurgeon #stanford #stanfordneurosurgery #pituitarydisease

This morning, our residents welcomed director of the USC Brain Tumor Center, Gabriel Zada, MD, MS, FAANS, who presented his talk “Less Invasive, More Impactful: Translational Research Driving Progress in Cranial Neurosurgery”. Dr. Zada is a Professor of Neurological Surgery and Physiology and Neuroscience at Keck Medicine of USC Neurosurgery. . . . . #neurosurgery #neurosurgeon #stanford #stanfordneurosurgery #brainresearch #cranial

Congratulations?to Saurabh Sharma for receiving the Stanford Brain Metastasis Consortium (SBMC) Seed Grant! Sharma, a postdoctoral fellow with the Kirane Lab, in the Department of Surgery, will receive $50k to fund his research on melanoma brain metastasis therapies, entitled “Immuno-Nano-Conjugates: Precision Engineering for Targeting the Brain Tumor-immune Microenvironment in Checkpoint-Refractory Melanoma Metastasis”. Saurabh is mentored by Dr. Amanda?Kirane and Dr. Michael Lim, and will participate in monthly Brain MetNet meetings, including two short presentations, first to introduce himself and his project; and second to provide a progress update. #stanford #grant #award #neurosurgery

Continuing #EpilepsyAwarenessMonth we focus on a study from Dr. H. Westley Phillips and his lab: this study is looking at the correlation between the electrophysiologic and genetic signatures of epilepsy. It was found that regions with higher mutation burden were more epileptogenic which may provide clues to the genetic underpinnings of epilepsy. The figure is a representation of somatic mosaicism of a pathogenic PIK3CA E542K variant which correlates with the seizure onset zone localization in a 9-year-old patient with drug-resistant epilepsy and a left frontal malformation of cortical development (MCD) who underwent a sEEG-informed left frontal disconnection with peri-electrode biopsies. (Phillips et al. Neurology Genetics. 2023) Read here: https://lnkd.in/gyQY6kD4

November is Epilepsy Awareness Month, and we recognize the millions of people worldwide who live with this brain disorder. We stand with them and their families, caregivers, and loved ones in the fight to continue advancements and find a cure.?#EpilepsyAwareness

Congratulations to Dr. Irene Llorente for receiving funding for her DISC2 grant ($2.3M)! The studies funded by the DISC2 grant will determine the effect of newly developed glial cell-based therapy on behavioral recovery, neuronal network function, and cellular and molecular mechanisms of repair after mild traumatic brain injury (mTBI). It is estimated that 100-300 per 100,000 people seek medical attention for mTBI annually worldwide. Nearly, 32,900 people diagnosed with non-fatal TBI are hospitalized in California each year. Amazing achievement! #stanford

Congratulations to PGY-5 Resident Lily Kim, MD, for receiving a first place award for Basic Science Research at the 2024 Korean American Medical Association Scientific Convention “Collaboration in Healthcare” in Seoul, Korea.